Status:
COMPLETED
Proteomic Analysis of Human Hepatocellular Carcinoma
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
Carcinoma, Hepatocellular
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This is a pilot study to evaluate the difference between the protein expression between hepatocellular carcinoma and tumor with vessel invasion in Asian patients with hepatocellular carcinoma.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Arm A: Hepatocellular carcinoma with vessel invasion:
- hepatocellular carcionoma, pathologic diagnosed.
- image documented vessel invasion, including portal vein thrombosis
- eligible for surgical intervension.
- Arm B: hepatocellular carcinoma without vessel invasion:
- hepatocellular carcinoma, pathologic diagnosed or clinical diagnosed according to EASL criteria.
- no vessel invasion on image.
- Arm C: Healthy hepatitis carrier:
- patients age \>18 years old with hepatitis B or C
- normal liver function.
Exclusion
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT01177631
Start Date
February 1 2009
End Date
January 1 2010
Last Update
February 5 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Far Eastern Memorial Hospital
Taipei, Taiwan, 220